Herbert Virgin - 22 Sep 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: EVP, Research & CSO
Signature: /s/ Howard Horn, Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 22 Sep 2021
Net transactions value: +$12,240
Form type: 4
Filing time: 24 Sep 2021, 17:00:18 UTC
Previous filing: 22 Sep 2021
Next filing: 06 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Options Exercise	$12,240	+8,000	+8%	$1.53^*	107,700	22 Sep 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Stock Option (Right to Buy)	Options Exercise	$0	-8,000	-3.1%	$0.000000	251,130	22 Sep 2021	Common Stock	8,000	$1.53	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.